Try our beta test site
828 studies found for:    hiv vaccine
Show Display Options
Rank Status Study
1 Completed Safety and Immunogenicity Study of tgAAC09, a Gag-PR-RT AAV HIV Vaccine
Condition: HIV Infection
Intervention: Biological: tgAAC09
2 Recruiting Study of Safety and Immunogenicity of HIV Vaccines in Healthy Volunteers
Conditions: Healthy Volunteer;   HIV Vaccine
Interventions: Biological: Ad4-mgag;   Biological: Ad4-EnvC150
3 Completed Safety & Immunogenicity of Immunisations With EN41-UGR7C HIV Vaccine
Condition: - HIV
Interventions: Biological: EN41-UGR7C HIV vaccine;   Biological: NaCl
4 Completed Long-term Follow-up of Participants From Studies Evaluating GSK HIV Vaccine
Condition: AIDS
Interventions: Procedure: Blood collection;   Biological: GSK HIV vaccine 732462
5 Completed Safety and Immunogenicity Study of 2 Investigational Preventive HIV Vaccines
Condition: HIV Infections
Interventions: Biological: Adjuvanted GSK investigational HIV vaccine formulation 1;   Biological: Adjuvanted GSK investigational HIV vaccine formulation 2;   Biological: Ad35 investigational HIV vaccine;   Biological: Placebo (saline)
6 Completed Safety and Immunogenicity of a Plasmid HIV Vaccine in HIV Uninfected Adults
Condition: HIV Infection
Intervention: Biological: ADVAX
7 Completed Safety of the HIV Vaccine 732461 in HIV Infected Subjects Aged 18 to 55 Years Old
Condition: HIV (Human Immunodeficiency Virus)-Infected Adults
Interventions: Biological: HIV Vaccine 732461;   Biological: Placebo vaccine
8 Completed
Has Results
HIV Testing & Womens Attitudes on HIV Vaccine Trials
Condition: HIV
Intervention: Behavioral: Message Sidedness
9 Completed Efficacy and Safety of GSK Biologicals HIV Vaccine in Antiretroviral Therapy (ART)-naïve HIV-1 Infected Persons
Condition: AIDS
Interventions: Biological: GSK Biologicals HIV Vaccine 732462;   Drug: Placebo
10 Completed Safety and Immunogenicity Study of SeV-G(NP) HIV Vaccine Administered Intranasally and Ad35-GRIN HIV Vaccine Given Intramuscularly in Prime-Boost Regimens in HIV-Uninfected Volunteers
Condition: HIV Infections
Interventions: Biological: SeV-G(NP) (0.2mL, 2x10^7 CIU);   Biological: SeV-G(NP) (0.2mL, 2x10^8 CIU);   Biological: Ad35-GRIN (0.5mL)
11 Completed An HIV Vaccine Preparedness Study
Condition: HIV Infections
Intervention: Behavioral: Vaccine preparedness
12 Completed A Study of Safety, Tolerability and Immunogenicity of a 1-Dose Regimen of MRKAd5 HIV-1 Gag Vaccine Versus the ALVAC_HIV Vaccine (V520-019)
Condition: HIV-1 Infection
Interventions: Biological: V520;   Biological: Comparator: ALVAC-HIV vaccine
13 Completed Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative Volunteers
Condition: Acquired ImmunoDeficiency Syndrome (AIDS)
Intervention: Biological: HIV vaccine 732461
14 Completed EuroNeut41: Safety & Immunogenicity of Immunisations With HIV Vaccine
Condition: HIV
Interventions: Biological: EN41-FPA2 HIV vaccine;   Biological: Na Cl Placebo vaccine
15 Completed Study to Evaluate the Dosage and Safety of Two Intramuscular Injections of an Investigational Clade B HIV Vaccine
Condition: HIV
Interventions: Biological: Investigational HIV vaccine dose A;   Biological: Investigational HIV vaccine dose B
16 Not yet recruiting An HIV Vaccine Trial in Individuals Who Started ART During Primary or Chronic Infection
Condition: Hiv
Interventions: Biological: GTU-MultiHIV B-clade vaccine;   Biological: MVA HIV-B HIV vaccine;   Biological: Placebo 1: Sodium Chloride;   Biological: Placebo 2:S08 buffer
17 Completed A Study to Prepare for Future HIV Vaccine Studies
Condition: HIV Infections
Intervention:
18 Completed A Trial to Evaluate Ad35-GRIN/ENV HIV Vaccine in Healthy Adult Volunteers
Conditions: HIV;   HIV Infections
Interventions: Biological: Ad35-GRIN/ENV;   Biological: Ad35-GRIN
19 Completed Safety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected Adults
Condition: HIV Infections
Intervention: Biological: VRC-HIVADV014-00-VP
20 Active, not recruiting Study to Evaluate the Safety and Immunogenicity of Orally-administered HIV Vaccine in Healthy, HIV-uninfected Adult Participants
Conditions: Healthy Volunteer;   HIV Vaccine
Interventions: Biological: Ad4-mgag;   Biological: Ad4-EnvC150;   Other: Placebo Comparator;   Biological: AIDSVAX B/E

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.